Mark Cushman
- Toxicology top 0.02%
- Bioactive Compounds and Antitumor Agents 64
- Organic Chemistry top 0.2%
- Synthesis and biological activity 32
- Synthesis and Biological Evaluation 25
- Molecular Biology top 1%
- Cancer therapeutics and mechanisms 84
- Synthesis and bioactivity of alkaloids 23
- Chemical Synthesis and Analysis 15
- Cancer Research top 2%
- Pharmacology top 0.5%
-
- Estrogen and related hormone effects 19
-
- HIV/AIDS drug development and treatment 17
- Co-authors
- Yves PommierSmitha AntonyGlenda KohlhagenAndrew MorrellErnest HamelKeli AgamaXiangshu XiaoDhanapalan Nagarathnam
- Journals
- Journal of Medicinal Chemistry (72 papers)The Journal of Organic Chemistry (32 papers)Bioorganic & Medicinal Chemistry Letters (13 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Mark Cushman
214 papers receiving 8.3k citations
Peers
Comparison fields: 5 of 117
- Toxicology 1.6k
- Organic Chemistry 4.5k
- Molecular Biology 4.8k
- Cancer Research 938
- Pharmacology 959
Countries citing papers authored by Mark Cushman
This map shows the geographic impact of Mark Cushman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cushman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cushman more than expected).
Fields of papers citing papers by Mark Cushman
This network shows the impact of papers produced by Mark Cushman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cushman. The network helps show where Mark Cushman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Cushman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 9 | |
| 2 | 2019 | 2 | |
| 3 | 2019 | 16 | |
| 4 | 2018 | 32 | |
| 5 | 2016 | 19 | |
| 6 | 2016 | 25 | |
| 7 | 2015 | 59 | |
| 8 | 2014 | 80 | |
| 9 | 2011 | 30 | |
| 10 | 2011 | 57 | |
| 11 | 2011 | 16 | |
| 12 | 2007 | 113 | |
| 13 | Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance | 2007 | 1 |
| 14 | 2006 | 36 | |
| 15 | 2005 | 27 | |
| 16 | 2002 | 3 | |
| 17 | 2002 | 53 | |
| 18 | 2000 | 4 | |
| 19 | 1998 | 12 | |
| 20 | 1995 | 166 |
About Mark Cushman
Mark Cushman is a scholar working on Toxicology, Organic Chemistry and Virology, having authored 215 papers that have together received 8.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (84 papers), Bioactive Compounds and Antitumor Agents (64 papers), Synthesis and biological activity (32 papers), Synthesis and Biological Evaluation (25 papers), Synthesis and bioactivity of alkaloids (23 papers), Estrogen and related hormone effects (19 papers), HIV/AIDS drug development and treatment (17 papers) and Chemical Synthesis and Analysis (15 papers). The work is most often cited by research in Toxicology (1.6k citations), Organic Chemistry (4.5k citations) and Molecular Biology (4.8k citations). Mark Cushman has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Yves Pommier, Smitha Antony, Glenda Kohlhagen, Andrew Morrell, Ernest Hamel, Keli Agama, Xiangshu Xiao, Dhanapalan Nagarathnam, Lance Stewart and Bart L. Staker. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.